BridgeMD
Tests treatment safety and results for Wheat Hypersensitivity
Official title Comparison Efficacy Between Two Different Frequency of Maintenance Dose Oral Immunotherapy
ClinicalTrials.gov ID: NCT06035328
What this study is testing
- What it's testing
- Oral immunotherapy(OIT) is effective in desensitized food allergy. OIT protocols are not standardized, and a wide heterogeneity exists in the literature .
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 18
You may be able to join if
- Age 5-18 years old
- Children aged 5-18 years with history of IgE mediated wheat allergy and positive OFC test
- Reach target maintenance dose of wheat OIT and ongoing to maintenance phase of wheat OIT
You likely can't join if
- Patient with low dose OIT protocol
- Patients with uncontrolled atopic dermatitis, uncontrolled asthma, or any chronic disease;
- Patients who had been treated with some other immunotherapy (eg, SLIT, another OIT) or biologic therapy (eg, Omalizumab)
- Patients with a developmental problem or mental disorder
- Active eosinophilic gastrointestinal disease in the past 2 years
- Use of b-blockers (oral), angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, or calcium-channel blockers
See the full eligibility criteria
- Age 5-18 years old
- Children aged 5-18 years with history of IgE mediated wheat allergy and positive OFC test
- Reach target maintenance dose of wheat OIT and ongoing to maintenance phase of wheat OIT
- Patient with low dose OIT protocol
- Patients with uncontrolled atopic dermatitis, uncontrolled asthma, or any chronic disease;
- Patients who had been treated with some other immunotherapy (eg, SLIT, another OIT) or biologic therapy (eg, Omalizumab)
- Patients with a developmental problem or mental disorder
- Active eosinophilic gastrointestinal disease in the past 2 years
- Use of b-blockers (oral), angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, or calcium-channel blockers
- Pregnancy or lactation
- Patient who could not visit clinic as protocol
The study team makes the final eligibility decision.
Where it's taking place
- Bangkoknoi, Bangkok, Thailand
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bangkoknoi, Bangkok, Thailand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.